A Wearable Electrostimulator for
Parkinson’s disease is a neurodegenerative disorder, with general symptoms such as tremors, rigidity, bradykinesia, and postural instability. Symptoms worsen as the disease progresses and the patient’s quality of life is vastly impaired.
This medical breakthrough is an electro-stimulator which can be attached to the patient’s ear; it is a brand new device developed to reduce patients’ symptoms to a level achieved with medication. Patients currently experience many undesirable side effects due to the medications they use; this device, however, has no side effects whatsoever. It will also be an alternative for the very expensive and risky deep brain stimulation (DBS) procedure. This breakthrough is the result of a pioneering study in its field - its development still in progress.
A large number of clinical trials have been conducted with the device and are continuing. You can access detailed information via the Clinical Research page.
January 25, 2019
2019 World Parkinson Conference Presentation
Clinical study results will be presented in World Parkinson Conference 2019. Click here for further details of the conference.
October 15, 2017
US patent is granted!
The US patent was granted in October 2017. As of now, the FDA application can be pursued for the US market.
June 25, 2017
The article in relation to the Short-term Effect Clinical Trial has been published in the Frontiers in Human Neuroscience journal!
The results of the Short-term Effect Clinical Trials were published in June 2017 as an article in the Frontiers’ in Human Neuroscience journal. This journal is a highly regarded publication in this field; the details of which can be accessed via the Publication section on the Research tab.
June 15, 2017
European Patent is granted!
The European Patent was granted on June, 2017. Therefore, the process of entering the market in both Turkey and European countries will be gaining speed.
June 01, 2016
Preliminary results of our clinical study is presented in Neuromodulation: The Science 2016 Conference held in San Francisco.